93 related articles for article (PubMed ID: 22321781)
1. [Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].
Zhou KS; Yu Z; Yi SH; Li ZJ; An G; Wang YY; Zou DH; Qi JY; Zhao YZ; Song YP; Qiu LG
Zhonghua Yi Xue Za Zhi; 2011 Sep; 91(34):2384-7. PubMed ID: 22321781
[TBL] [Abstract][Full Text] [Related]
2. [The expression of microRNA-155 and microRNA-146a and its' clinical value in chronic lymphoproliferative disorders].
Zhou KS; Yu Z; Yi SH; Li ZJ; Li YF; An G; Zou DH; Qi JY; Zhao YZ; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):656-9. PubMed ID: 22339821
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
Zhou K; Yi S; Yu Z; Li Z; Wang Y; Zou D; Qi J; Zhao Y; Qiu L
Leuk Lymphoma; 2012 Jun; 53(6):1155-61. PubMed ID: 22145958
[TBL] [Abstract][Full Text] [Related]
4. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
5. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
[TBL] [Abstract][Full Text] [Related]
6. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
[TBL] [Abstract][Full Text] [Related]
7. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
[TBL] [Abstract][Full Text] [Related]
8. Repertoire of Rearranged Immunoglobulin Heavy Chain Genes in Russian Patients With B-Cell Lymphoproliferative Diseases.
Biderman BV; Likold EB; Smirnova SY; Nikitin EA; Koroleva DA; Zvonkov EE; Al-Radi LS; Julhakyan HL; Sudarikov AB
Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):e938-e945. PubMed ID: 34384734
[TBL] [Abstract][Full Text] [Related]
9. CD 200 - A useful marker in chronic B lymphoprolipherative disorders.
Iova A; Vlădăreanu A; Bumbea H; Begu M; Vasile D; Andruş E
J Med Life; 2012; 5(Spec Issue):66-70. PubMed ID: 31803290
[No Abstract] [Full Text] [Related]
10. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
12. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
13. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
[TBL] [Abstract][Full Text] [Related]
14. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
15. [Overrepresentation of specific gene segments of expressed immunoglobulin heavy chain variable region among unmutated and mutated patients with chronic lymphocytic leukemia].
Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Qi JY; Li CH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):529-32. PubMed ID: 22338175
[TBL] [Abstract][Full Text] [Related]
16. [Expression of LATS mRNA in mantle cell lymphoma and its clinical significance].
Yu Z; Yi S; Zhang Y; Li Z; Qiu L
Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(40):3285-8. PubMed ID: 26815349
[TBL] [Abstract][Full Text] [Related]
17. [Clonality analysis and mutation status of IgVH genes in classic Richter's syndrome].
Mao ZR; Rosenwald A; Zhang SJ; Zhou R; Mueller-Hermelink HK
Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):364-70. PubMed ID: 19031714
[TBL] [Abstract][Full Text] [Related]
18. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.
van't Veer MB; Brooijmans AM; Langerak AW; Verhaaf B; Goudswaard CS; Graveland WJ; van Lom K; Valk PJ
Haematologica; 2006 Jan; 91(1):56-63. PubMed ID: 16434371
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]